Citation: L. Arvanitis et al., SEROQUEL(TM) (ICI-204-636) - A NOVEL, ATYPICAL ANTIPSYCHOTIC - EFFICACY AND SAFETY RESULTS FROM 2 PHASE-II, MULTICENTER, PLACEBO-CONTROLLEDCLINICAL-TRIALS, Schizophrenia research, 15(1-2), 1995, pp. 142-142
Authors:
FABRE LF
ARVANITIS L
PULTZ J
JONES VM
MALICK JB
SLOTNICK VB
Citation: Lf. Fabre et al., ICI-204,636, A NOVEL, ATYPICAL ANTIPSYCHOTIC - EARLY INDICATION OF SAFETY AND EFFICACY IN PATIENTS WITH CHRONIC AND SUBCHRONIC SCHIZOPHRENIA, Clinical therapeutics, 17(3), 1995, pp. 366-378